Memorial Sloan Kettering forms collaboration with Quest Diagnostics

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MEMORIAL SLOAN KETTERING CANCER CENTER and Quest Diagnostics announced a joint collaboration that will focus on gene mutations associated with solid tumors. Financial terms of the agreement were not disclosed.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login